Baxter Blood Thinner Drug Heparin Put On Hold

Boston (dbTechno) - The Baxter blood thinner drug Heparin has been stopped in terms of manufacturing of the drug as they found that the drug, in the multiple-dose vials, can cause severe reactions among patients, including dropping blood pressure so low that they are at risk of going into shock.

The FDA stated on Monday in a statement that in some cases the blood pressure of patients would drop so low that they were at risk of life-threatening shock.

Other severe reactions from the drug Heparin include vomiting, difficulty breathing, and more.

Since receiving injections of Heparin, there have been four reported deaths thus far.

Baxter is the producer of half of the multi-dose vials of Heparin in the U.S. according to the FDA.

The FDA is “investigating whether similar events have been seen with other heparin manufacturers.”

The reactions all occured when patients took a high dose of Heprain in a short period of time. The lower dose patients were not at as high of a risk.